UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 17

of 'Treatment of relapsed or refractory mantle cell lymphoma'

17
TI
Lenalidomide in relapsed/refractory mantle cell lymphoma post-bortezomib: Subgroup analysis of the MCL-001 study (abstract 8534)
AU
Williams ME
SO
J Clin Oncol. 2013;31:526s.
 
AD